Overview

Addition of Dydrogesterone to the Luteal Phase Support After Fresh Embryo Transfer

Status:
Not yet recruiting
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
Randomized controlled study, open label to compare effectiveness of addition of dydrogesterone 20mg to the standard luteal phase support treatment after fresh embryos transfer.
Phase:
N/A
Details
Lead Sponsor:
Laniado Hospital
Treatments:
Dydrogesterone